Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 10, 2010, Pages 2253-2254

  Karthikeyan, Kumarasamy ^a   Thirunarayan, M A ^b   Krishnan, Padma ^a  

^a UNIVERSITY OF MADRAS   (India)

^b APOLLO HOSPITALS   (India)

Author keywords

High level resistance to aminoglycosides; ISAba1; Mixed carbapenemases

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEMASE; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METHYLTRANSFERASE; NETILMICIN; NMPA PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RMTA PROTEIN; RMTB PROTEIN; RMTC PROTEIN; RMTD PROTEIN; RNA 16S; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; BACTERIAL DNA; BETA LACTAMASE; BETA LACTAMASE NDM 1; BETA LACTAMASE OXA 23; BETA-LACTAMASE NDM-1; BETA-LACTAMASE OXA-23; TRANSFER RNA METHYLTRANSFERASE;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARMA GENE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLA NDM 1 GENE; BLA OXA 23 GENE; BROTH DILUTION; CONJUGATION; DRUG MECHANISM; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC RESISTANCE; HUMAN; INDIA; INTENSIVE CARE UNIT; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; SCREENING TEST; TERTIARY HEALTH CARE; ACINETOBACTER INFECTION; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; TRNA METHYLTRANSFERASES;

EID: 77957232485     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq273     Document Type: Letter

References (11)

1. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
2. Bercot B, Poirel L, Nordman P. Plasmid-mediated 16S rRNA methylases among extended-spectrum b-lactamase-producing Enterobacteriaceae isolates. Antimicrob Agents Chemother 2008; 52: 4526-7.
3. Turton JF, Ward ME, Woodford N et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258: 72-7.
4. Ellington MJ, Kistler J, Livermore DM et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother 2007; 59: 321-2.
5. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents Chemother 2009; 53: 5046-54.
6. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
7. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007; 45: 88-94.
8. Bogaerts P, Galimand M, Bauraing C et al. Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J Antimicrob Chemother 2007; 59: 459-64.
9. Wachino J, Shibayama K, Kurokawa H et al. Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob Agents Chemother 2007; 51: 4401-9.
10. NDM-1 in Enterobacteriaceae from India. In: Abstracts of the Twentieth European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 2010. Abstract P-742. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
11. NDM-1 metallo-β-lactamase in enteric organisms from India is mostly linked to A/C type plasmids. In: Abstracts of the Twentieth European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 2010. Abstract O-134. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.